Low-density lipoprotein cholesterol outcomes post-non-PCSK9i lipid-lowering therapies in atherosclerotic cardiovascular disease and probable heterozygous familial hypercholesterolemia patients

Low-density lipoprotein cholesterol outcomes post-non-PCSK9i lipid-lowering therapies in atherosclerotic cardiovascular disease and probable heterozygous familial hypercholesterolemia patients

Chi-Chang Chen,1 Pallavi B Rane,2 Dionne M Hines,1 Jeetvan Patel,2 David J Harrison,2 Rolin L Wade1 1IQVIA, Plymouth Meeting, PA, USA; 2Amgen Inc., Thousand Oaks, CA, USA Background: This study evaluated the proportion of patients with atherosclerotic cardiovascular disease (ASCVD) and probable he...

Full description

Bibliographic Details
Main Authors: Chen CC, Rane PB, Hines DM, Patel J, Harrison DJ, Wade RL
Format: Article
Language:English
Published: Dove Medical Press 2018-12-01
Series:Therapeutics and Clinical Risk Management
Subjects:
hyperlipidemia
ASCVD
HeFH
LDL-C
statin
Online Access:https://www.dovepress.com/low-density-lipoprotein-cholesterol-outcomes-post-non-pcsk9i-lipid-low-peer-reviewed-article-TCRM

Internet

https://www.dovepress.com/low-density-lipoprotein-cholesterol-outcomes-post-non-pcsk9i-lipid-low-peer-reviewed-article-TCRM

Similar Items